SAN CARLOS, Calif., Nov 28, 2006 (BUSINESS WIRE) -- Nektar Therapeutics (Nasdaq:NKTR) announced today that its corporate presentation will be webcast live by the BMO Capital Markets Focus on Healthcare Conference in New York, on Wednesday, December 6 at 4:00pm (Eastern Time). The presentation by Dr. Christopher Searcy, vice president of corporate development, may be accessed live on the investor relations' page at www.nektar.com and will be available for two weeks following the webcast.
Nektar Therapeutics is a biopharmaceutical company that develops and enables differentiated therapeutics with its industry-leading drug delivery technologies, expertise and manufacturing capabilities. Nektar technology and know-how have enabled nine approved products for partners, which include the world's leading pharmaceutical and biotechnology companies. Nektar also develops its own products by applying its drug delivery technologies and expertise to existing medicines to enhance performance, such as improving efficacy, safety and compliance.
SOURCE: Nektar Therapeutics
Nektar Therapeutics Joyce Strand, 650-631-3138 Jennifer Ruddock, 650-631-4954
Copyright Business Wire 2006
News Provided by COMTEX